SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chunjing Lin, Hai Zou, Shumin Wang, Hepatitis B e Antigen Seroconversion Is Related with the Function of Dendritic Cells in Chronic Hepatitis B Virus Infection, Gastroenterology Research and Practice, 2014, 2014, 1

    CrossRef

  2. 2
    Yong-Yuan Zhang, Ke-Qin Hu, Zhongping Duan, New perspective on the natural course of chronic HBV infection, Frontiers of Medicine, 2014, 8, 2, 129

    CrossRef

  3. 3
    Ranjit Chauhan, Shiv K. Sarin, Manoj Kumar, Jayashree Bhattacharjee, Naturally occurring core immune-escape and carboxy-terminal mutations\truncations in patients with e antigen negative chronic hepatitis B, Hepatology International, 2012, 6, 4, 707

    CrossRef

  4. 4
    Akinsegun A Akinbami, Olajumoke O Oshinaike, Owolabi A Dosunmu, Titilope A Adeyemo, Adewumi Adediran, Sulaiman Akanmu, Kikelomo O Wright, Seun Ilori, Kinsley Aile, Seroprevalence of hepatitis B e antigen (HBe antigen) and B core antibodies (IgG anti-HBcore and IgM anti-HBcore) among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria, BMC Research Notes, 2012, 5, 1, 167

    CrossRef

  5. 5
    María Mora González López Ledesma, Omar Galdame, Belén Bouzas, Luciana Tadey, Beatriz Livellara, Silvina Giuliano, Marcela Viaut, Silvia Paz, Hugo Fainboim, Adrian Gadano, Rodolfo Campos, Diego Flichman, Characterization of the basal core promoter and precore regions in anti-HBe-positive inactive carriers of hepatitis B virus, International Journal of Infectious Diseases, 2011, 15, 5, e314

    CrossRef

  6. 6
    Seoung-Ae Lee, Yoo-Kyung Cho, Keun-Hwa Lee, Eung-Soo Hwang, Yoon-Hoh Kook, Bum-Joon Kim, Gender disparity in distribution of the major hydrophilic region variants of hepatitis B virus genotype C according to hepatitis B e antigen serostatus, Journal of Medical Virology, 2011, 83, 3
  7. 7
    Emanuel K. Manesis, George V. Papatheodoridis, Dina G. Tiniakos, Emilia S. Hadziyannis, Olga P. Agelopoulou, Thalia Syminelaki, Christos Papaioannou, Theodoros Nastos, Peter Karayiannis, Hepatitis B surface antigen: Relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B, Journal of Hepatology, 2011, 55, 1, 61

    CrossRef

  8. 8
    Abdel-Rahman El-Zayadi, Hanaa Mostafa Badran, Ahmed Saied, Sherine Shawky, Mohy El-Deen Attia, Khaled Zalata, Evaluation of Liver Biopsy in Egyptian HBeAg-Negative Chronic Hepatitis B Patients at Initial Presentation: Implications for Therapy, The American Journal of Gastroenterology, 2009, 104, 4, 906

    CrossRef

  9. 9
    Hyung Joon Yim, Hepatitis B virus genetic diversity and mutant, The Korean Journal of Hepatology, 2008, 14, 4, 446

    CrossRef

  10. 10
    Claudio Galli, Elisa Orlandini, Luigi Penzo, Renzo Badiale, Giacomo Caltran, Sara Valverde, Gianluca Gessoni, What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology?, Journal of Medical Virology, 2008, 80, 6
  11. 11
    Sabahattin Kaymakoglu, Ahmet Danalioglu, Kadir Demir, Cetin Karaca, Filiz Akyuz, Derya Onel, Selim Badur, Ugur Cevikbas, Fatih Besisik, Yilmaz Cakaloglu, Atilla Okten, Long-Term Results of Interferon Alpha Monotherapy in Patients with HBeAg-Negative Chronic Hepatitis B, Digestive Diseases and Sciences, 2007, 52, 3, 727

    CrossRef

  12. 12
    E. K. MANESIS, G. V. PAPATHEODORIDIS, S. J. HADZIYANNIS, A partially overlapping treatment course with lamivudine and interferon in hepatitis B e antigen-negative chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2006, 23, 1
  13. 13
    Y.-H. Huang, J.-C. Wu, T.-T. Chang, I.-J. Sheen, T.-I. Huo, P.-C. Lee, C.-W. Su, S.-D. Lee, Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients, Journal of Viral Hepatitis, 2006, 13, 5
  14. 14
    Emanuel K. Manesis, HBeAg-negative chronic hepatitis B: From obscurity to prominence, Journal of Hepatology, 2006, 45, 3, 343

    CrossRef

  15. 15
    Angelos Hatzakis, Emmanouil Magiorkinis, Catherine Haida, HBV virological assessment, Journal of Hepatology, 2006, 44, S71

    CrossRef

  16. 16
    Scott K. Fung, Florence S. H. Wong, David K. H. Wong, Munira T. Hussain, Anna S. F. Lok, Hepatitis B virus genotypes, precore and core promoter variants among predominantly Asian patients with chronic HBV infection in a Canadian center, Liver International, 2006, 26, 7
  17. 17
    Teresa L. Wright, Introduction to Chronic Hepatitis B Infection, The American Journal of Gastroenterology, 2006, 101, S1, S1

    CrossRef

  18. 18
    XiaoHong Sun, Akinori Rokuhara, Eiji Tanaka, Amal Gad, Hidetomo Mutou, Akihiro Matsumoto, Kaname Yoshizawa, Kendo Kiyosawa, Nucleotide mutations associated with hepatitis B e antigen negativity, Journal of Medical Virology, 2005, 76, 2
  19. 19
    Jean-Pierre Villeneuve, The natural history of chronic hepatitis B virus infection, Journal of Clinical Virology, 2005, 34, S139

    CrossRef

  20. 20
    S. Gaia, A. Marzano, A. Smedile, V. Barbon, M. L. Abate, A. Olivero, M. Lagget, S. Paganin, M. Fadda, G. Niro, M. Rizzetto, Four years of treatment with lamivudine: clinical and virological evaluations in HBe antigen-negative chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2004, 20, 3
  21. 21
    M. KHAN, J J. DONG, S. K. ACHARYA, Y. DHAGWAHDORJ, Z. ABBAS, W. JAFRI SM, D. H. MULYONO, N. TOZUN, S. K. SARIN, Hepatology issues in Asia: Perspectives from regional leaders, Journal of Gastroenterology and Hepatology, 2004, 19,
  22. 22
    I.S Elefsiniotis, C Mpotsi, K.D Pantazis, V Paparizos, Long-term follow-up of HIV/HBV coinfected patients from a Greek center, Journal of Clinical Virology, 2004, 30, 3, 280

    CrossRef

  23. 23
    Rosendo Jardi, Francisco Rodriguez, Maria Buti, Xose Costa, Auristela Valdes, Helena Allende, Melanie Schaper, Roman Galimany, Rafael Esteban, Jaime Guardia, Mutations in the basic core promoter region of hepatitis B virus. Relationship with precore variants and HBV genotypes in a Spanish population of HBV carriers, Journal of Hepatology, 2004, 40, 3, 507

    CrossRef

  24. 24
    S. K. Fung, F. Wong, M. Hussain, A. S. F. Lok, Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis B, Journal of Viral Hepatitis, 2004, 11, 5
  25. 25
    Bernhard Zöllner, Jörg Petersen, Elisabeth Puchhammer-Stöckl, Josef Kletzmayr, Martina Sterneck, Lutz Fischer, Matthias Schröter, Rainer Laufs, Heinz-Hubert Feucht, Viral features of lamivudine resistant hepatitis B genotypes A and D, Hepatology, 2004, 39, 1
  26. 26
    Charlotte L. Cameron-Wilson, Peter Muir, Anna L. Ballard, Sally Corden, Elizabeth H. Boxall, Erwin Sablon, Lieven Stuyver, Evaluation of a line probe assay for identification of hepatitis B virus precore variants in serum from chronic hepatitis B carriers, Journal of Virological Methods, 2003, 114, 1, 97

    CrossRef

  27. 27
    S Corden, A.L Ballard, S Ijaz, J.A.J Barbara, N Gilbert, R.J.C Gilson, E.H Boxall, R.S Tedder, HBV DNA levels and transmission of hepatitis B by health care workers, Journal of Clinical Virology, 2003, 27, 1, 52

    CrossRef

  28. 28
    Ioannis S Elefsiniotis, Ioannis Ketikoglou, Georgia Kafiri, Konstantinos D Pantazis, Antonios Moulakakis, Christos Mavrogiannis, Plasma pituitary adenylate cyclase activating polypeptide (PACAP) levels in chronic hepatitis B patients under lamivudine treatment, European Journal of Gastroenterology & Hepatology, 2003, 15, 11, 1209

    CrossRef

  29. 29
    Byung Chul Yoo, Joong-Won Park, Hyung Joon Kim, Dong Ho Lee, Young Ju Cha, Sill Moo Park, Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea, Journal of Hepatology, 2003, 38, 1, 98

    CrossRef

  30. 30
    Pietro Andreone, Maurizio Biselli, Annagiulia Gramenzi, Carmela Cursaro, Maria C. Morelli, Claudia Sama, Stefania Lorenzini, Giulio Spinucci, Federica Porzio, Francesco Felline, Loriana Di Giammarino, Mauro Bernardi, Efficacy of lamivudine therapy for advanced liver disease in patients with precore mutant hepatitis B virus infection awaiting liver transplantation1, Transplantation, 2002, 74, 8, 1119

    CrossRef

  31. 31
    SK SARIN, SK SATAPATHY, R CHAUHAN, Hepatitis B e-antigen negative chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2002, 17,
  32. 32
    Andreas Laras, John Koskinas, Stephanos J. Hadziyannis, In Vivo Suppression of Precore mRNA Synthesis Is Associated with Mutations in the Hepatitis B Virus Core Promoter, Virology, 2002, 295, 1, 86

    CrossRef

  33. 33
    M. L. Funk, D. M. Rosenberg, A. S. F. Lok, World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants, Journal of Viral Hepatitis, 2002, 9, 1
  34. 34
    G. V. Papatheodoridis, S. J. Hadziyannis, Diagnosis and management of pre-core mutant chronic hepatitis B, Journal of Viral Hepatitis, 2001, 8, 5
  35. 35
    Charles P Lollo, Mariusz G Banaszczyk, Charles R Ill, Christopher C Coffin, Michael A Lucas, Henry C Chiou, Gene therapy strategies for the treatment of chronic viral hepatitis, Expert Opinion on Biological Therapy, 2001, 1, 4, 629

    CrossRef

  36. 36
    Guido François, Michael Kew, Pierre Van Damme, M.Jeffrey Mphahlele, André Meheus, Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications?, Vaccine, 2001, 19, 28-29, 3799

    CrossRef

  37. 37
    P.R. Smith, R. Zampino, C. Gutteridge, P. Karayiannis, C. Aitken, Reactivation of precore variant hepatitis B virus in a child with severe aplastic anaemia, Journal of Medical Virology, 2001, 65, 3
  38. 38
    C. Liatsos, A. B. Mehta, M. Potter, A. K. Burroughs, The hepatologist in the haematologists' camp, British Journal of Haematology, 2001, 113, 3
  39. 39
    George V Papatheodoridis, Emanuel Manesis, Stephanos J Hadziyannis, The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis B, Journal of Hepatology, 2001, 34, 2, 306

    CrossRef

  40. 40
    Henry L. Y. Chan, Nancy W. Y. Leung, Munira Hussain, May L. Wong, Anna S. F. Lok, Hepatitis B e antigen–negative chronic hepatitis b in Hong Kong, Hepatology, 2000, 31, 3
  41. 41
    Gerald Y Minuk, Pamela S Orr, Rosemay Brown, Sharon Macdonald, Rabinda K Chaudhary, Paula Temple, Pre-core mutant infections in the Canadian Inuit, Journal of Hepatology, 2000, 33, 5, 781

    CrossRef

  42. 42
    Arie Regev, Eugene R. Schiff, VIRAL HEPATITIS A, B, AND C, Clinics in Liver Disease, 2000, 4, 1, 47

    CrossRef

  43. 43
    Nicolaos C. Tassopoulos, Riccardo Volpes, Giuseppe Pastore, Jenny Heathcote, Maria Buti, Robert D. Goldin, Sasha Hawley, Judy Barber, Lynn Condreay, D. Fraser Gray, Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB, Hepatology, 1999, 29, 3
  44. 44
    S. L. Ngui, R. Hallet, C. G. Teo, Natural and iatrogenic variation in hepatitis B virus, Reviews in Medical Virology, 1999, 9, 3